BlackRock Fund Advisors’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$14.8M	Buy	3,894,087 +445,087	+13%	+$3.23M	﹤0.01%	2351
2016 Q3	$30.9M	Buy	3,449,000 +345,672	+11%	+$2.89M	0.01%	1859
2016 Q2	$21.8M	Buy	3,103,328 +255,785	+9%	+$2.34M	﹤0.01%	1976
2016 Q1	$24.2M	Buy	2,847,543 +318,167	+13%	+$3.13M	0.01%	1874
2015 Q4	$33.2M	Sell	2,529,376 -141,489	-5%	-$1.27M	0.01%	1750
2015 Q3	$9.78M	Buy	2,670,865 +101,091	+4%	+$494K	﹤0.01%	2381
2015 Q2	$14.8M	Sell	2,569,774 -3,875	-0.2%	-$22.4K	﹤0.01%	2290
2015 Q1	$15M	Buy	2,573,649 +122,799	+5%	+$847K	﹤0.01%	2218
2014 Q4	$19.2M	Buy	2,450,850 +200,158	+9%	+$1.28M	﹤0.01%	2090
2014 Q3	$11.1M	Buy	2,250,692 +3,255	+0.1%	+$17K	﹤0.01%	2290
2014 Q2	$13.9M	Buy	2,247,437 +61,809	+3%	+$309K	﹤0.01%	2222
2014 Q1	$11.7M	Buy	2,185,628 +110,428	+5%	+$698K	﹤0.01%	2307
2013 Q4	$10.9M	Buy	2,075,200 +12,196	+0.6%	+$56K	﹤0.01%	2347
2013 Q3	$11.4M	Buy	2,063,004 +370,015	+22%	+$1.28M	﹤0.01%	2280
2013 Q2	$4.28M	Buy	+1,692,989	New	+$4.22M	﹤0.01%	2789